4-aminoquinazoline has been researched along with Multiple Myeloma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Abibi, A; Al-Awar, R; Aman, A; Chung, KC; Griffin, C; Grouleff, J; Isaac, MB; Joseph, B; Kiyota, T; Konda, JD; Ler, S; Leung-Hagesteijn, C; Marcellus, R; Poda, G; Prakesch, MA; Strathdee, CA; Subramaniam, R; Tiedemann, RE; Uehling, DE; Zhang, AX | 1 |
1 other study(ies) available for 4-aminoquinazoline and Multiple Myeloma
Article | Year |
---|---|
Design, Synthesis, and Characterization of 4-Aminoquinazolines as Potent Inhibitors of the G Protein-Coupled Receptor Kinase 6 (GRK6) for the Treatment of Multiple Myeloma.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; G-Protein-Coupled Receptor Kinases; Humans; Mice; Models, Molecular; Molecular Structure; Multiple Myeloma; Protein Kinase Inhibitors; Quinazolines; Structure-Activity Relationship | 2021 |